Review

A New Target in Inflammatory Diseases: Lycopene

Volume 54 · Issue 1 · January 2022 Publish Date: January 11, 2023
Full Text PDF
DOI
Zeynep Karaköy
Department of Pharmacology, Erzincan Binali Yildirim University, Faculty of Pharmacy, Erzincan, Turkey
Elif Cadirci
Department of Pharmacology, Ataturk University, Faculty of Medicine, Erzurum, Turkey
Busra Dincer
Department of Pharmacology, Erzincan Binali Yildirim University, Faculty of Pharmacy, Erzincan, Turkey
Karaköy, Z., Cadirci, E., & Dincer, B. (2023). A New Target in Inflammatory Diseases: Lycopene. The Eurasian Journal of Medicine, 54(1), S23-S28. https://doi.org/10.5152/eurasianjmed.2022.22303
Full Text Full Text PDF

Abstract

nflammation is a response to various injuries, illnesses, and severe trauma. The primary function of inflammation is to combat pathogens, eliminate them from the body, and initiate wound healing. However, inflammation also contributes to numerous diseases, such as cancer, cardiovascular disease, diabetes, obesity, osteoporosis, rheumatoid arthritis, inflammatory bowel disease, and asthma. As the importance of nutrition in maintaining human health has become increasingly recognized, the consumption of natural antioxidants has gained popularity, especially in developed countries. A growing body of research has shown that consuming foods rich in lycopene can protect individuals from a range of conditions, including cancer, heart disease, and other diseases. As a result, lycopene is gaining recognition as a potential protective antioxidant in the fields of medicine and pharmacology. This review aims to highlight the effects of lycopene on inflammatory diseases and provide a foundational understanding for researchers interested in further research on lycopene.

Cite this article as: Karaköy Z, Cadirci E, Dincer B. A new target in inflammatory diseases: Lycopene. Eurasian J Med., 2022;54(Suppl. 1):S23-S28.

Similar Articles

Article Info
Published In
Journal The Eurasian Journal of Medicine
Volume / Issue Volume 54 · Issue 1 · January 2022
Pages S23-S28
History
Published Online January 11, 2023
License
Copyright
Affiliations
Zeynep Karaköy
Department of Pharmacology, Erzincan Binali Yildirim University, Faculty of Pharmacy, Erzincan, Turkey
Elif Cadirci
Department of Pharmacology, Ataturk University, Faculty of Medicine, Erzurum, Turkey
Busra Dincer
Department of Pharmacology, Erzincan Binali Yildirim University, Faculty of Pharmacy, Erzincan, Turkey
Cite this Article
Karaköy, Z., Cadirci, E., & Dincer, B. (2023). A New Target in Inflammatory Diseases: Lycopene. The Eurasian Journal of Medicine, 54(1), S23-S28. https://doi.org/10.5152/eurasianjmed.2022.22303
Share
Outlines